Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

40.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.0K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

2.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.0K
Sympathetic Pathways: Sympathetic Chain Ganglia01:20

Sympathetic Pathways: Sympathetic Chain Ganglia

4.1K
The sympathetic chain ganglia, also known as the sympathetic trunk ganglia or paravertebral ganglia, are a series of ganglia located bilaterally on either side of the spinal column. These ganglia serve as relay stations for the sympathetic nervous system. Preganglionic neurons originating in the spinal cord project their axons to the sympathetic chain ganglia. Within the ganglia, these preganglionic fibers synapse with postganglionic neurons.The postganglionic neurons of the sympathetic trunk...
4.1K
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

3.9K
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
3.9K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Therapeutic adherence among asthma patients: Variations according to age groups. How can it be improved? The potential contributions of new technologies].

Revue des maladies respiratoires·2022
Same author

[Hiccups, not always unremarkable].

Revue medicale de Liege·2022
Same author

[Community-acquired Staphylococcus aureus pneumonia].

Revue medicale de Liege·2021
Same author

[An illustrative case of the POEMS syndrome].

Revue medicale de Liege·2021
Same author

Retraction: Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells.

Journal of cell science·2021
Same author

Continuous infusion of cefepime and neurotoxicity: a retrospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Related Experiment Video

Updated: Nov 3, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K

[Paraneoplastic neurological syndromes].

N Lambert1, L Lutteri2, B Sadzot1

  • 1Service de Neurologie, CHU Liège, Belgique.

Revue Medicale De Liege
|June 3, 2021
PubMed
Summary
This summary is machine-generated.

Neurological paraneoplastic syndromes are cancer complications caused by immune responses to tumor cells. Prompt diagnosis and treatment of these syndromes are crucial for revealing and managing the underlying cancer.

Keywords:
ImmunotherapyNeurological paraneoplastic syndromesCancer

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.9K

Related Experiment Videos

Last Updated: Nov 3, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.2K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.4K
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
08:59

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

10.9K

Area of Science:

  • Neuro-oncology
  • Immunology
  • Oncology

Background:

  • Neurological paraneoplastic syndromes are non-metastatic complications of systemic cancers.
  • They often result from immune responses triggered by tumor cells expressing neuronal antigens.
  • Common examples include cerebellar degeneration, sensory neuronopathy, limbic encephalitis, encephalomyelitis, and Lambert-Eaton myasthenic syndrome.

Purpose of the Study:

  • To highlight the importance of prompt cancer screening in patients with neurological paraneoplastic syndromes.
  • To emphasize the association between specific syndromes, antibodies, and tumor types.
  • To underscore the significance of early diagnosis for identifying underlying malignancies.

Main Methods:

  • Review of clinical presentations of neurological paraneoplastic syndromes.
  • Correlation of specific syndromes with associated antibodies and tumor types.
  • Emphasis on diagnostic and therapeutic strategies.

Main Results:

  • Neurological paraneoplastic syndromes frequently indicate an underlying cancer.
  • A particular syndrome is often linked to a specific antibody and a corresponding tumor.
  • Early detection of these syndromes can lead to the discovery of occult cancers.

Conclusions:

  • Prompt diagnosis of neurological paraneoplastic syndromes is vital for identifying underlying cancers.
  • Treatment involves addressing both the neoplasia and the immune response.
  • Cancer screening is essential for patients presenting with these neurological manifestations, especially those with risk factors.